The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Open accessAbstract
Liver fibrosis is a consequence of chronic liver diseases and thus a major cause of mortality and morbidity. Clinical evidence and animal studies suggest that local tissue homeostasis is disturbed due to immunological responses to chronic hepatocellular stress. Poorly defined stress-associated inflammatory networks are thought to mediate gradual accumulation of extracellular-matrix components, ultimately leading to fibrosis and liver failure. Here we have reported that hepatic expression of interleukin-33 (IL-33) was both required and sufficient for severe hepatic fibrosis in vivo. We have demonstrated that IL-33's profibrotic effects related to activation and expansion of liver resident innate lymphoid cells (ILC2). We identified ILC2-derived IL-13, acting through type-II IL-4 receptor-dependent signaling via the transcription factor STAT6 and hepatic stellate-cell activation, as a critical downstream cytokine of IL-33-dependent pathologic tissue remodeling and fibrosis. Our data reveal key immunological networks implicated in hepatic fibrosis and support the concept of modulation of IL-33 bioactivity for therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, ILC2s (via IL-33), T cells (via IL-17), B cells (immunoglobulin independent), Tregs (via amphiregulin) and platelets have been suggested to directly promote HSC activation [197, 237, 242–245].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · cites this paper as [242]
In the citing paper
“Together, these data suggest complex roles for IL-33 and ILC-2 in NASH and possibly thresholds for IL-33 that need to be surpassed to modulate fibrosis.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [87]
In the citing paper
“IL-33-mediated expansion of ILC2s was shown to promote toxin-induced liver fibrosis through an IL-13-IL4R-STAT6 pathway.87”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [87]
In the citing paper
“a modified version of this model in which bleomycin is injected intra-dermally rather than intra-tracheally over several weeks uncovered a substantial role for IL-4R signaling in the development of pulmonary fibrosis141”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M. G., Langford, T. K. A., Bucks, C. M., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 2,079
Self-citationInnate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2009) · Nature · doi:10.1038/nature08636 · Cited by 1,994
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,728
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G. K., Doering, T. A., Angelosanto, J., Laidlaw, B. J., Yang, C. Y., Sathaliyawala, T., et al. (2011) · Nature Immunology · doi:10.1038/ni.2131 · Cited by 1,327
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,134
Flagged first, then by citations
2 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 504
Jie, Z., Liang, Y., Hou, L., Dong, C., Iwakura, Y., Soong, L., Cong, Y., & Sun, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303281 · Cited by 43
Wang, M., Shen, G., Xu, L., Liu, X., Brown, J. M., Feng, D., Ross, R. A., Gao, B., Liangpunsakul, S., & Ju, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.023 · Cited by 44
Role of the IL-33/ST2L axis in colorectal cancer progression
Akimoto, M., & Takenaga, K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.014 · Cited by 42
Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis
Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 47
IFN-γ Directly Controls IL-33 Protein Level through a STAT1- and LMP2-dependent Mechanism
Kopach, P., Lockatell, V., Pickering, E. M., Haskell, R. E., Anderson, R. D., Hasday, J. D., Todd, N. W., Luzina, I. G., & Atamas, S. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534396 · Cited by 41
Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury
Cameron, G. J. M., Cautivo, K. M., Loering, S., Jiang, S., Deshpande, A., Foster, P. S., McKenzie, A. N. J., Molofsky, A. B., Hansbro, P. M., & Starkey, M. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00826 · Cited by 40
Self-citationType 1 innate lymphoid cells: Soldiers at the front line of immunity
Nabekura, T., & Shibuya, A. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.10.001 · Cited by 42
Luo, J., Liang, Y., Kong, F., Qiu, J., Liu, X., Chen, A., Luxon, B. A., Wu, H. W., & Wang, Y. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.109 · Cited by 40
A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia
Mack, C. L., Spino, C., Alonso, E. M., Bezerra, J. A., Moore, J., Goodhue, C. J., Ng, V. L., Karpen, S. J., Venkat, V. L., Loomes, K. M., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002256 · Cited by 40
Innate Lymphoid Cells in Tumor Immunity
van Beek, J. J. P., Martens, A. W. J., Bakdash, G., & de Vries, I. J. M. (2016) · Biomedicines · doi:10.3390/biomedicines4010007 · Cited by 40
Group 2 innate lymphocytes at the interface between innate and adaptive immunity
Schuijs, M. J., & Halim, T. Y. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13604 · Cited by 40
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics
Khanam, A., & Kottilil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02013 · Cited by 40
The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?
Artlett, C. M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.012 · Cited by 41
The role of IL‐22 in the resolution of sterile and nonsterile inflammation
Alabbas, S. Y., Begun, J., Florin, T. H., & Oancea, I. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1017 · Cited by 37
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms
Sutton, H., Karpen, S. J., & Kamath, B. M. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-025623 · Cited by 39
Shen, G., Wang, Q., Li, Z., Xie, J., Han, X., Wei, Z., Zhang, P., Zhao, S., Wang, X., Huang, X., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.96338 · Cited by 38
The role of innate lymphoid cells in health and disease
Mohammadi, H., Sharafkandi, N., Hemmatzadeh, M., Azizi, G., Karimi, M. H., Jadidi‐Niaragh, F., Baradaran, B., & Babaloo, Z. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26250 · Cited by 42
Gonzalez-Polo, V., Molineris, M. P., Cervera, V., Gambaro, S. E., Yantorno, S. E., Descalzi, V., Tiribelli, C., Gondolesi, G. E., & Meier, D. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.12.001 · Cited by 39
Helper-like innate lymphoid cells and cancer immunotherapy
Crinier, A., Vivier, É., & Bléry, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.002 · Cited by 37
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis
Izadi, D., Layton, T. B., Williams, L. M., McCann, F. E., Cabrita, M., Santo, A. I. E., Xie, W., Fritzsche, M., Colin‐York, H., Feldmann, M., et al. (2019) · Science Advances · doi:10.1126/sciadv.aay0370 · Cited by 38
Therapeutic manipulation of innate lymphoid cells
Cobb, L., & Verneris, M. R. (2021) · JCI Insight · doi:10.1172/jci.insight.146006 · Cited by 32
Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Liedtke, C., Nevzorova, Y. A., Luedde, T., Zimmermann, H. W., Kroy, D. C., Strnad, P., Berres, M., Bernhagen, J., Tacke, F., Nattermann, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814496 · Cited by 43
Innate lymphoid cells in autoimmunity and chronic inflammatory diseases
Xiong, T., & Turner, J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0670-4 · Cited by 37
Innate lymphoid cells in organ fibrosis
Mikami, Y., Takada, Y., Hagihara, Y., & Kanai∥, T. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.07.002 · Cited by 39
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling
Chiriac, M. T., Hracskó, Z., Günther, C., González-Acera, M., Atreya, R. N., Stolzer, I., Wittner, L., Dressel, A., Schickedanz, L., Gámez‐Belmonte, R., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329628 · Cited by 36
Self-citationInnate lymphoid cells, possible interaction with microbiota
Moro, K., & Koyasu, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0470-4 · Cited by 36
Interferon‐γ constrains cytokine production of group 2 innate lymphoid cells
Kudo, F., Ikutani, M., Seki, Y., Otsubo, T., Kawamura, Y. I., Dohi, T., Oshima, K., Hattori, M., Nakae, S., Takatsu, K., et al. (2015) · Immunology · doi:10.1111/imm.12537 · Cited by 36
Tissue-resident NK cells and other innate lymphoid cells
Zhou, J., Tian, Z., & Peng, H. C. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.002 · Cited by 37
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
Aziz, N. A., Musaigwa, F., Mosala, P., Berkiks, I., & Brombacher, F. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.005 · Cited by 37
Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells
Murphy, J. M., Ngai, L., Mortha, A., & Crome, S. Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836999 · Cited by 36
Perivascular stromal cells: Directors of tissue immune niches
Sbierski‐Kind, J., Mroz, N. M., & Molofsky, A. B. (2021) · Immunological Reviews · doi:10.1111/imr.12984 · Cited by 35
The role of the interleukin family in liver fibrosis
Zhang, Z., Wang, J., Li, H., Niu, Q. F., Tao, Y., Zhao, X., Zeng, Z., & Dong, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1497095 · Cited by 36
Mouse models for the study of fate and function of innate lymphoid cells
Cording, S., Medvedovic, J., Lécuyer, E., Aychek, T., Déjardin, F., & Eberl, G. (2018) · European Journal of Immunology · doi:10.1002/eji.201747388 · Cited by 34
Loh, Z., Fitzsimmons, R. L., Reid, R. C., Ramnath, D., Clouston, A. D., Gupta, P. K., Irvine, K. M., Powell, E. E., Schroder, K., Stow, J. L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14768 · Cited by 35
The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases
Liu, M., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00695 · Cited by 33
Development of allergic immunity in early life
Lloyd, C. M., & Saglani, S. (2017) · Immunological Reviews · doi:10.1111/imr.12562 · Cited by 35
Xu, Z., Zhao, C., Wang, Z., Tao, J., Han, Z., Zhang, W., Tan, R., & Gu, M. (2017) · Gene · doi:10.1016/j.gene.2017.11.010 · Cited by 33
Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
Xie, C., Zhu, J., Wang, X., Chen, J., Geng, S., Wu, J., Zhong, C., & Li, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1052-z · Cited by 33
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells
Liang, Y., Wang, X., Wang, H., Yang, W., Yi, P., Soong, L., Cong, Y., Cai, J., Fan, X., & Sun, J. (2021) · Immunology · doi:10.1111/imm.13404 · Cited by 35
Transcription Factors Controlling Innate Lymphoid Cell Fate Decisions
Klose, C. S. N., & Diefenbach, A. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_381 · Cited by 32
IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice
Pavlovic, S. M., Petrović, I., Jovicic, N. U., Ljujić, B., Kovačević, M. M., Arsenijević, N., & Lukić, M. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02646 · Cited by 32
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Flores‐Borja, F., Irshad, S., Gordon, P., Wong, F., Sheriff, I., Tutt, A. N. J., & Ng, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/7803091 · Cited by 33
Therapeutic modulation of the liver immune microenvironment
Tilg, H., Adolph, T. E., & Tacke, F. (2023) · Hepatology · doi:10.1097/hep.0000000000000386 · Cited by 32
Regulation of systemic metabolism by tissue-resident immune cell circuits
Li, J. H., Hepworth, M. R., & O’Sullivan, T. E. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.001 · Cited by 36
The Fate of Activated Group 2 Innate Lymphoid Cells
Mathä, L., Martínez-González, I., Steer, C. A., & Takei, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671966 · Cited by 33
Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells
Steinmann, S., Schoedsack, M., Heinrich, F., Breda, P. C., Ochel, A., Tiegs, G., & Neumann, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-57985-w · Cited by 32
The role of interleukin-33 in organ fibrosis
Carmine, S. D., Scott, M. M., McLean, M. H., & McSorley, H. J. (2022) · Discovery Immunology · doi:10.1093/discim/kyac006 · Cited by 32
Ghali, R., Habeichi, N. J., Kaplan, A., Tannous, C., Abidi, E., Bekdash, A., Farhat, R., Itani, H. A., Jurjus, A. R., Booz, G. W., et al. (2020) · Clinical Science · doi:10.1042/cs20200402 · Cited by 30
Mathä, L., Romera‐Hernández, M., Steer, C. A., Yin, Y. H., Orangi, M., Shim, H. B., Chang, C.-K., Rossi, F. M. V., & Takei, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679509 · Cited by 31
Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum
Yu, Y., Deng, W., & Lei, J. (2015) · Parasitology Research · doi:10.1007/s00436-015-4492-1 · Cited by 30
Vachliotis, I. D., & Pοlyzos, S. A. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00657-5 · Cited by 31
Innate lymphoid cells as regulators of the tumor microenvironment
Tugues, S., Ducimetière, L., Friebel, E., & Becher, B. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.002 · Cited by 31
Gatti, F., Mia, S., Hammarström, C. L., Frerker, N., Fosby, B., Wang, J., Pietka, W., Sundnes, O., Fosse, J. H., Kasprzycka, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80509-5 · Cited by 29
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone
Haep, N., Florentino, R. M., Squires, J. E., Bell, A. W., & Soto–Gutiérrez, A. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1725023 · Cited by 31
Examination of the role of necroptotic damage-associated molecular patterns in tissue fibrosis
Liu, X., Lu, F., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886374 · Cited by 30
Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer
An, Z., Flores‐Borja, F., Irshad, S., Deng, J., & Ng, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03111 · Cited by 30
Papadimitriou, T. I., van Caam, A., van der Kraan, P. M., & Thurlings, R. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020316 · Cited by 30
PTPRO-Associated Hepatic Stellate Cell Activation Plays a Critical Role in Liver Fibrosis
Zhang, X., Tan, Z., Wang, Y., Tang, J., Jiang, R., Hou, J., Zhuo, H., Wang, X., Ji, J., Qin, X., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369746 · Cited by 28
Localization and site-specific cell–cell interactions of group 2 innate lymphoid cells
Kiniwa, T., & Moro, K. (2021) · International Immunology · doi:10.1093/intimm/dxab001 · Cited by 27
Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
Nagai, N., Kudo, Y., Aki, D., Nakagawa, H., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052238 · Cited by 30
Lechner, K., Mott, S., Al-Saifi, R., Knipfer, L., Wirtz, S. J., Atreya, R. N., Vieth, M. W., Räth, T., Fraass, T., Winter, Z., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.072 · Cited by 27
Self-citationThe Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis
Nagashima, R., & Iyoda, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688647 · Cited by 27
Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis
Varlamova, E. G., Goltyaev, M. V., Rogachev, V. V., Gudkov, S. V., Karaduleva, E. V., & Turovsky, E. A. (2023) · Cells · doi:10.3390/cells12232723 · Cited by 29
Kamdem, S. D., Konhawa, F., Kuemkon, E. M., Kamguia, L. M., Tchanana, G. K., Nche, F., Oumarou, A., Hamza, M., Ouratou, Y., Tcheutchoua, M. N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02827 · Cited by 25
IL-33–ILC2 axis in the female reproductive tract
Miller, J. E., Koti, M., & Tayade, C. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.006 · Cited by 25
Tumor immunotherapy: Mechanisms and clinical applications
Nong, C., Guan, P., Li, L., Zhang, H., & Hu, H. (2022) · MedComm – Oncology · doi:10.1002/mog2.8 · Cited by 27
Kindermann, M., Knipfer, L., Obermeyer, S., Müller, U., Alber, G., Bogdan, C., Schleicher, U., Neurath, M. F., & Wirtz, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00209 · Cited by 26
Self-citationGerlach, K., Popp, V., Wirtz, S., Al-Saifi, R., Gonzalez Acera, M., Atreya, R., Dregelies, T., Vieth, M., Fichtner-Feigl, S., McKenzie, A. N. J., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac097 · Cited by 25
Self-citationInnate lymphoid cells in asthma
Vercelli, D., Gozdz, J., & von Mutius, E. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000023 · Cited by 25
Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
Wan, M., Han, J., Ding, L., Hu, F., & Gao, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604894 · Cited by 27
Nono, J. K., Ndlovu, H., Aziz, N. A., Mpotje, T., Hlaka, L., & Brombacher, F. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005861 · Cited by 25
Sun, Z., Chang, B., Huang, A., Hao, S., Gao, M., Sun, Y. H., Shi, M., Jin, L., Zhang, W., Zhao, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13990 · Cited by 24
Hepatic immune regulation by stromal cells
Schildberg, F. A., Sharpe, A. H., & Turley, S. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.002 · Cited by 26
Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?
Maggi, E., Veneziani, I., Moretta, L., Cosmi, L., & Annunziato, F. (2020) · Cancers · doi:10.3390/cancers12113452 · Cited by 24
Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
Sunaga, S., Tsunoda, J., Teratani, T., Mikami, Y., & Kanai∥, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867351 · Cited by 26
Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis
Vasseur, P., Dion, S., Filliol, A. A., Genêt, V., Lucas‐Clerc, C., Girard, J., Silvain, C., Lecron, J., Piquet‐Pellorce, C., & Samson, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18335 · Cited by 24
Huang, M., Wang, D., Huang, J., Bae, A.-N., Xia, Y., Zhao, X., Mortaja, M., Azin, M., Collier, M. R., Semenov, Y. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60894-z · Cited by 23
Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression
Crombruggen, K. V., Taveirne, S., Holtappels, G., Leclercq, G., & Bachert, C. (2018) · European Respiratory Journal · doi:10.1183/13993003.00742-2018 · Cited by 23
Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis–induced Profibrogenic Alterations in Bone Marrow
Nakashima, T., Liu, T., Hu, B., Wu, Z. B., Ullenbruch, M. R., Omori, K., Ding, L., Hattori, N., & Phan, S. H. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1560oc · Cited by 25
Li, Z., Xiao, L., Lin, G., Tang, J., Chen, Y., Chen, L., Li, B., Wu, M., Liu, S., Huang, C., et al. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3542-4 · Cited by 23
NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis
Nilsson, J., Hörnberg, M., Schmidt-Christensen, A., Linde, K., Nilsson, M., Carlus, M., Erttmann, S. F., Mayans, S., & Holmberg, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-78688-2 · Cited by 23
The IL-33-ILC2 pathway protects from amebic colitis
Uddin, M. J., Leslie, J. L., Burgess, S. L., Oakland, D. N., Thompson, B. A., Abhyankar, M. M., Revilla, J., Frisbee, A. L., Donlan, A. N., Kumar, P., et al. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00442-2 · Cited by 23
Sati, S., Huang, J., Kersh, A. E., Jones, P., Ahart, O., Murphy, C. M., Prouty, S. M., Hedberg, M. L., Jain, V., Gregory, S. G., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178711 · Cited by 23
Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?
Wenink, M. H., Leijten, E. F. A., Cupedo, T., & Radstake, T. R. D. J. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40068 · Cited by 23
Sankar, K. N., Pearson, A. N., Worlikar, T., Perricone, M. D., Holcomb, E. A., Mendiratta‐Lala, M., Xu, Z., Bhowmick, N. A., & Green, M. D. (2023) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-11 · Cited by 22
Afshar, K., Sanaei, M., Ravari, M. S., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3846 · Cited by 23
Trained innate lymphoid cells in allergic diseases
Ebihara, T., Tatematsu, M., Fuchimukai, A., Yamada, T., Yamagata, K., Takasuga, S., & Yamada, T. (2020) · Allergology International · doi:10.1016/j.alit.2020.11.007 · Cited by 22
Group 2 innate lymphoid cells and their surrounding environment
Naito, M., & Kumanogoh, A. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00272-8 · Cited by 21
Interleukin-33 Promotes Disease Progression in Patients with Primary Biliary Cirrhosis
Sun, Y., Zhang, J., Lv, S., Wang, H., Gong, M., Du, N., Liu, H., Zhang, N., Jing, J., Zhou, C., et al. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.234.255 · Cited by 21
Group 2 ILC s: A way of enhancing immune protection against human helminths?
Nausch, N., & Mutapi, F. (2017) · Parasite Immunology · doi:10.1111/pim.12450 · Cited by 22
ILC2s in infectious diseases and organ-specific fibrosis
Kindermann, M., Knipfer, L., Atreya, I., & Wirtz, S. J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0677-x · Cited by 24
Self-citationZhang, Y., Zhu, H., Layritz, F., Luo, H., Wohlfahrt, T., Chen, C., Soare, A., Bergmann, C., Ramming, A., Groeber, F., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41259 · Cited by 22
Mukendi, J. P. K., Nakamura, R., Uematsu, S., & Hamano, S. (2021) · Parasites & Vectors · doi:10.1186/s13071-020-04561-w · Cited by 21
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
An, S. Y., Petrescu, A. D., & DeMorrow, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645703 · Cited by 21
Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes
Painter, J. D., & Akbari, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727008 · Cited by 21
Flow cytometric analysis of innate lymphoid cells: challenges and solutions
Sadeghalvad, M., Khijakadze, D., Orangi, M., & Takei, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198310 · Cited by 20
Reißing, J., Berres, M., Strnad, P., Wree, A., Inzaugarat, M. E., Trautwein, C., Bruns, T., & Zimmermann, H. W. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.011 · Cited by 20
All along the watchtower: group 2 innate lymphoid cells in allergic responses
Dahlgren, M. W., & Molofsky, A. B. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.008 · Cited by 20
Innate lymphoid cells in kidney diseases
Wang, R., Wang, Y., Harris, D. C. H., & Cao, Q. (2020) · Kidney International · doi:10.1016/j.kint.2020.11.023 · Cited by 20
Establishment and function of tissue-resident innate lymphoid cells in the skin
Yang, J., Zhao, L., Xu, M., & Xiong, N. (2017) · Protein & Cell · doi:10.1007/s13238-017-0388-4 · Cited by 20
Metadata
- Authors
- Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., & Wirtz, S.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- MRC Laboratory of Molecular Biology (GB)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Wirtz, Stefan
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 39
- Issue
- 2
- Pages
- 357-371
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC4172965
- OpenAlex
- W1997883939
- Cited by
- 502
- References
- 54
- Citations by year
- 2026: 13 · 2025: 33 · 2024: 30 · 2023: 33 · 2022: 35 · 2021: 37 · 2020: 46 · 2019: 43 · 2018: 48 · 2017: 50 · 2016: 47 · 2015: 47 · 2014: 35 · 2013: 4
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- IL-33, liver fibrosis, innate lymphoid cells, ILC2, IL-13, STAT6, hepatic stellate cells, extracellular matrix remodeling, liver inflammation, chronic liver disease
- MeSH terms
- Interleukin-33, Animals, Cells, Cultured, Inflammation, Interleukins, Liver, Liver Cirrhosis, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Mice, Inbred C57BL, Signal Transduction, Mice, Knockout, Interleukin-13, Adoptive Transfer, Cell Proliferation, STAT6 Transcription Factor, Mice, Receptors, Interleukin-4, Type II, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review